| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 26 |
| 1 | PREDNISONE | 21 |
| 2 | OMEPRAZOLE MAGNESIUM | 18 |
| 3 | ENZALUTAMIDE | 16 |
| 4 | ERGOCALCIFEROL | 16 |
| 5 | ACETAMINOPHEN | 14 |
| 6 | AMLODIPINE | 14 |
| 7 | CARBOPLATIN | 14 |
| 8 | OMEPRAZOLE | 14 |
| 9 | RELUGOLIX | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CITRATE AND CITRIC ACID | 1 | 0.0208 |
| 1 | EPHEDRINE SULFATE | 2 | 0.0091 |
| 2 | GUAIFENESIN AND CODEINE PHOSPHATE | 1 | 0.0075 |
| 3 | PENICILLIN G POTASSIUM | 4 | 0.0055 |
| 4 | HYDROCHLORIC ACID | 1 | 0.0045 |
| 5 | OMEPRAOLE, SODIUM BICARBONATE | 1 | 0.0031 |
| 6 | POTASSIUM BICARBONATE | 2 | 0.0028 |
| 7 | PENICILLIN G SODIUM | 3 | 0.0026 |
| 8 | ERDAFITINIB | 3 | 0.0024 |
| 9 | BUPROPION HCL ER | 1 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 35 |
| 1 | Corticosteroid [EPC] | 34 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 31 |
| 3 | Kinase Inhibitor [EPC] | 26 |
| 4 | Proton Pump Inhibitor [EPC] | 21 |
| 5 | Androgen Receptor Inhibitor [EPC] | 18 |
| 6 | Factor Xa Inhibitor [EPC] | 17 |
| 7 | Opioid Agonist [EPC] | 16 |
| 8 | Platinum-based Drug [EPC] | 16 |
| 9 | Provitamin D2 Compound [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 3 | 0.0017 |
| 2 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 3 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 14 | 0.0005 |
| 4 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |
| 5 | Autologous Cellular Immunotherapy [EPC] | 3 | 0.0005 |
| 6 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 7 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 8 | CD19-directed Chimeric Antigen Receptor [EPC] | 4 | 0.0004 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 35 | 0.0004 |